OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. A variety of strategies can be employed to antibody titer, such as process parameter optimization, cell line development, and adoption of perfusion processes. Fine-tuning culture conditions